Figure 1.
Flow chart describing the selection of the study population.
Based on the exclusion criteria, 170 subjects were finally recruited for analyses.
Table 1.
Baseline characteristics (n = 170).
Figure 2.
Box plots of ELF test according to fibrosis stage.
Boxes and horizontal lines within boxes represent interquartile ranges (IQRs) and median values, respectively. The upper and lower whiskers indicate 75th percentile plus 1.5 IQR and 25th percentile minus 1.5 IQR, respectively. o, mild outlier: a value more than 75th percentile plus 1.5 IQR, but less than 75th percentile plus 3.0 IQR.
Figure 3.
Receiver operating characteristic (ROC) curves for ELF test, LSM and FT in the diagnosis of significant fibrosis (≥F2, A), advanced fibrosis (≥F3, B), and cirrhosis (F = 4, C).
Table 2.
Diagnostic performances of LSM, FT and ELF and their suggested optimal cutoff values.
Figure 4.
Detailed AUROCs of ELF test, LSM and FT in the diagnosis of significant fibrosis (≥F2), advanced fibrosis (≥F3), and cirrhosis (F = 4).
Table 3.
Distribution and agreement of fibrosis stages according to histology and ELF, LSM or FT (n = 170).